Evidence map

TrialESC heart failure2025

Randomized trial to assess worsening renal function by adding dapagliflozin for acute decompensated heart failure.

Shodai Kawanami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

6 papers cite it

2025
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 39888286